Recent randomised controlled trials, such as ISCHEMIA and ORBITA, have overturned most of what we were taught in medical school about hospital procedures considered necessary for patients with stable coronary artery disease. In this article, we discuss what these trials mean for physicians and patients considering revascularisation procedures with the hope of reducing the risk of death or alleviating angina.
Keywords: coronary artery disease; ischaemia; left main coronary disease; percutaneous coronary intervention; stable angina.
© Royal College of Physicians 2021. All rights reserved.